Embecta Corp (EMBC)
14.19
+0.44
(+3.17%)
USD |
NASDAQ |
May 16, 16:00
14.19
0.00 (0.00%)
After-Hours: 17:40
Embecta Gross Profit Margin (Quarterly): 64.55% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.55% |
| December 31, 2023 | 67.04% |
| September 30, 2023 | 64.49% |
| June 30, 2023 | 66.24% |
| March 31, 2023 | 68.50% |
| December 31, 2022 | 68.48% |
| September 30, 2022 | 64.42% |
| Date | Value |
|---|---|
| June 30, 2022 | 69.70% |
| March 31, 2022 | 69.65% |
| December 31, 2021 | 70.48% |
| September 30, 2021 | 69.88% |
| June 30, 2021 | 68.68% |
| March 31, 2021 | 69.07% |
| December 31, 2020 | 67.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
64.42%
Minimum
Sep 2022
70.48%
Maximum
Dec 2021
67.73%
Average
68.49%
Median
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 81.54% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 30.58% |
| Electromed Inc | 74.85% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 5.76% |
| Return on Invested Capital | 8.77% |
| Profit Margin (Quarterly) | 10.06% |
| Operating Margin (Quarterly) | 13.65% |
| Return on Net Operating Assets | 10.65% |